BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 19959748)

  • 1. 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763), a glycogen synthase kinase-3 inhibitor, displays therapeutic properties in a mouse model of pulmonary inflammation and fibrosis.
    Gurrieri C; Piazza F; Gnoato M; Montini B; Biasutto L; Gattazzo C; Brunetta E; Cabrelle A; Cinetto F; Niero R; Facco M; Garbisa S; Calabrese F; Semenzato G; Agostini C
    J Pharmacol Exp Ther; 2010 Mar; 332(3):785-94. PubMed ID: 19959748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-12p40(-/-) mice treated with intratracheal bleomycin exhibit decreased pulmonary inflammation and increased fibrosis.
    Sakamoto H; Zhao LH; Jain F; Kradin R
    Exp Mol Pathol; 2002 Feb; 72(1):1-9. PubMed ID: 11784117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STY39, a novel alpha-melanocyte-stimulating hormone analogue, attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice.
    Xu PB; Mao YF; Meng HB; Tian YP; Deng XM
    Shock; 2011 Mar; 35(3):308-14. PubMed ID: 20926985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorofenidone attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice via restoring caveolin 1 expression and inhibiting mitogen-activated protein kinase signaling pathway.
    Meng J; Zou Y; Hu C; Zhu Y; Peng Z; Hu G; Wang Z; Tao L
    Shock; 2012 Nov; 38(5):567-73. PubMed ID: 23042199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleomycin-induced pulmonary fibrosis is independent of eosinophils.
    Hao H; Cohen DA; Jennings CD; Bryson JS; Kaplan AM
    J Leukoc Biol; 2000 Oct; 68(4):515-21. PubMed ID: 11037973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF and IL-6 mediate MIP-1alpha expression in bleomycin-induced lung injury.
    Smith RE; Strieter RM; Phan SH; Lukacs N; Kunkel SL
    J Leukoc Biol; 1998 Oct; 64(4):528-36. PubMed ID: 9766634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 beta, SB216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via inhibition of the mitochondrial permeability transition pore.
    Obame FN; Plin-Mercier C; Assaly R; Zini R; Dubois-Randé JL; Berdeaux A; Morin D
    J Pharmacol Exp Ther; 2008 Jul; 326(1):252-8. PubMed ID: 18434587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glycogen synthase kinase inhibitor 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763) is a partial agonist of the aryl hydrocarbon receptor.
    Braeuning A; Buchmann A
    Drug Metab Dispos; 2009 Aug; 37(8):1576-80. PubMed ID: 19448134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suplatast tosilate prevents bleomycin-induced pulmonary fibrosis in mice.
    Furonaka M; Hattori N; Tanimoto T; Senoo T; Ishikawa N; Fujitaka K; Haruta Y; Yokoyama A; Kohno N
    J Pharmacol Exp Ther; 2009 Jan; 328(1):55-61. PubMed ID: 18832650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of reactive nitrogen intermediate production in alveolar macrophage-mediated cytostatic activity induced by bleomycin lung damage in rats.
    Huot AE; Hacker MP
    Cancer Res; 1990 Dec; 50(24):7863-6. PubMed ID: 1701356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll like receptor 2 mediates bleomycin-induced acute lung injury, inflammation and fibrosis in mice.
    Liu HZ; Yang HZ; Mi S; Cui B; Hua F; Hu ZW
    Yao Xue Xue Bao; 2010 Aug; 45(8):976-86. PubMed ID: 21348427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of erythrocytes on alveolar macrophage cytostatic activity induced by bleomycin lung damage in rats.
    Huot AE; Gundel RM; Hacker MP
    Cancer Res; 1990 Apr; 50(8):2351-5. PubMed ID: 1690596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feitai, a Chinese herbal medicine, reduces transforming growth factor-beta1 and monocyte chemoattractant protein-1 expression in bleomycin-induced lung fibrosis in mice.
    Shen Y; Zhao HL; Du J; Li YT; Tan F; Huang CG; Pei G
    Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1071-7. PubMed ID: 16445573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azithromycin reduces pulmonary fibrosis in a bleomycin mouse model.
    Wuyts WA; Willems S; Vos R; Vanaudenaerde BM; De Vleeschauwer SI; Rinaldi M; Vanhooren HM; Geudens N; Verleden SE; Demedts MG; Thomeer M; Verbeken EK; Verleden GM
    Exp Lung Res; 2010 Dec; 36(10):602-14. PubMed ID: 20874225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases.
    Okuma T; Terasaki Y; Kaikita K; Kobayashi H; Kuziel WA; Kawasuji M; Takeya M
    J Pathol; 2004 Dec; 204(5):594-604. PubMed ID: 15538737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of emodin on bleomycin-induced pulmonary fibrosis in mice.
    Chen XH; Sun RS; Hu JM; Mo ZY; Yang ZF; Jin GY; Guan WD; Zhong NS
    Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):146-53. PubMed ID: 18785980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbon black nanoparticles enhance bleomycin-induced lung inflammatory and fibrotic changes in mice.
    Kamata H; Tasaka S; Inoue K; Miyamoto K; Nakano Y; Shinoda H; Kimizuka Y; Fujiwara H; Ishii M; Hasegawa N; Takamiya R; Fujishima S; Takano H; Ishizaka A
    Exp Biol Med (Maywood); 2011 Mar; 236(3):315-24. PubMed ID: 21427237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice.
    Saito F; Tasaka S; Inoue K; Miyamoto K; Nakano Y; Ogawa Y; Yamada W; Shiraishi Y; Hasegawa N; Fujishima S; Takano H; Ishizaka A
    Am J Respir Cell Mol Biol; 2008 May; 38(5):566-71. PubMed ID: 18096870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATLa, an aspirin-triggered lipoxin A4 synthetic analog, prevents the inflammatory and fibrotic effects of bleomycin-induced pulmonary fibrosis.
    Martins V; Valença SS; Farias-Filho FA; Molinaro R; Simões RL; Ferreira TP; e Silva PM; Hogaboam CM; Kunkel SL; Fierro IM; Canetti C; Benjamim CF
    J Immunol; 2009 May; 182(9):5374-81. PubMed ID: 19380784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of isoliensinine on bleomycin-induced pulmonary fibrosis in mice.
    Xiao JH; Zhang JH; Chen HL; Feng XL; Wang JL
    Planta Med; 2005 Mar; 71(3):225-30. PubMed ID: 15770542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.